AstraZeneca COVID vaccine – European product information – produced using human fetal cell line and GMO
https://www.ema.europa.eu/en/documents/product-information/vaxzevria-previously-covid-19-vaccine-astrazeneca-epar-product-information_en.pdf Page 2: Vaxzevria suspension for injection COVID-19 Vaccine (ChAdOx1-S [recombinant]). . . . . . One dose (0.5ml) contains: Chimpanzee Adenovirus encoding the SARS-CoV-2 Spike glycoprotein (ChAdOx1-S)*, not less than 2.5 × 108 infectious units (Inf.U) *Produced in genetically … Continue reading →